CNCE Past Earnings image   This CNCE past earnings page last updated 3/15/2023
CNCE Past Earnings
PeriodPast Earnings DateGAAP
Q3 202211/7/2022-0.580
Q2 20228/4/2022-0.590
Q1 20225/5/2022-1.030
Q4 20213/3/2022-1.010
Q3 202111/9/2021-0.780
Q2 20218/5/20210.160
Q1 20215/4/2021-0.670
Q4 20202/25/2021-0.690
Q3 202011/5/2020-0.600
Q2 20208/6/2020-0.410
Q1 20204/30/2020-0.700
Q4 20192/27/2020-0.860
Q3 201911/7/2019-0.720
Q2 20198/1/2019-0.780
Q1 20195/2/2019-0.930
Q4 20182/28/2019-0.89
Q3 201811/1/2018-0.74
Q2 20188/2/2018-0.57
Q1 20185/3/2018-0.19
Q4 20173/1/2018-0.26
Q3 201711/9/20175.44
Q2 20178/8/2017-0.58
Q1 20175/2/2017-0.6
Q4 20163/6/2017-0.54
Q3 201611/8/2016-0.51
Q2 20168/9/2016-0.6
Q1 20165/5/2016-0.63
Q4 20153/1/20160.03
Q3 201511/5/2015-0.39
Q2 20158/5/2015-0.37
Q1 20155/8/2015-0.48
Q4 20142/3/2015-0.56
Q3 201411/12/2014-0.43
Q2 20148/12/2014-0.45
Q1 20145/14/2014-0.76
FY 20133/31/2014-4.99
CNCE Past Revenue
PeriodPast Earnings DateGAAP
Q3 202211/7/20220.01M
Q2 20228/4/20220.02M
Q1 20225/5/2022NA
Q4 20213/3/20220.01M
Q3 202111/9/20210.00B
Q2 20218/5/20210.03B
Q1 20215/4/20210.01M
Q4 20202/25/20210.01M
Q3 202011/5/20200.00B
Q2 20208/6/20200.01B
Q1 20204/30/20200.01M
Q4 20192/27/20200.01M
Q3 201911/7/20190.01M
Q2 20198/1/20190.05M
Q1 20195/2/20190.00B
Q4 20182/28/201913000
Q3 201811/1/201811000
Q2 20188/2/20182000
Q1 20185/3/201810.48M
Q4 20173/1/201812000
Q3 201711/9/2017143.84M
Q2 20178/8/201715000
Q1 20175/2/201720000
Q4 20163/6/201721000
Q3 201611/8/201626000
Q2 20168/9/201671000
Q1 20165/5/201656000
Q4 20153/1/201610.30M
Q3 201511/5/20151.71M
Q2 20158/5/20153.25M
Q1 20155/8/20151.31M
Q4 20142/3/20151.31M
Q3 201411/12/20144.42M
Q2 20148/12/20141.24M
Q1 20145/14/20141.61M
FY 20133/31/201425.40M
Quotes delayed 20 minutes

Email EnvelopeFree CNCE Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Concert Pharmaceuticals (CNCE) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

CNMD Past Earnings
CNSP Past Earnings
CNST Past Earnings
CNTX Past Earnings
CNVY Past Earnings
COCP Past Earnings
CODX Past Earnings
COGT Past Earnings
COLL Past Earnings
COO Past Earnings

CNCE Past Earnings Q&A

What was the best and worst CNCE past earnings results?
For Concert Pharmaceuticals, I'm wondering what the company's very best and worst earnings results have been, on an earnings per share basis?

✔️Accepted answer: The highest CNCE past earnings result in our data set was 5.44/share posted in Q3 2017, while the lowest was in FY 2013 when CNCE posted -4.99/share.

  Suggested answer: The biggest top line earnings performance — aka revenue — quarter was in Q3 2017 when CNCE reported 143.84M in revenue, while the quarter with the lowest revenue in our data set was Q1 2022 at NA of revenue.

  Suggested answer: There are 36 CNCE past earnings results in our data set.

On this page we presented the CNCE past earnings date information for Concert Pharmaceuticals. Reviewing that CNCE Past Earnings for the company, we see that the highest past earnings result in our data set was in Q3 2017, when CNCE posted gaap of 5.44/share. Meanwhile the lowest CNCE past earnings result was in FY 2013, when CNCE posted gaap of -4.99/share. Turning to top line revenue performance, the biggest revenue quarter in our data set was seen in Q3 2017 when CNCE reported 143.84M in revenue, while the smallest revenue quarter was Q1 2022 when CNCE reported NA in revenue.

Any self directed investor doing their due diligence on CNCE or any other given stock can benefit from researching all of the Concert Pharmaceuticals past earnings — and here, we present each quarter's result all together on one page for easy comparison. Studying this information can help when projecting future earnings, as well as determining whether the past earnings trajectory justifies the current stock value. That's why we bring you to make it easy for investors to investigate Concert Pharmaceuticals past earnings, or the past earnings information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for CNCE. Thanks for visiting, and the next time you need to research CNCE past earnings or those of another stock, we hope you'll think of our site, as your go-to past earnings research resource of choice.

Recommended: VKTX Options Chain, LZB Dividend History, VTUS Historical Stock Prices.


CNCE Past Earnings | | Copyright © 2020 - 2023, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.